Biogen/ US09062X1037 /
| 2024-04-23 9:59:56 PM | Chg. -0.91 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 193.18USD | -0.47% | 49,292 Turnover: 9.56 mill. |
-Bid Size: - | -Ask Size: - | 28.08 bill.USD | - | 24.09 |
Assets
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,765.6830 | 2,187.6000 | 2,501.8000 | 3,182.4000 | 3,601.2000 | ||||||
| Intangible Assets | 4,028.5070 | 4,085.1000 | 3,808.3000 | 3,879.6000 | 3,120 | ||||||
| Long-Term Investments | 1,470.6520 | 2,760.4000 | 2,829.4000 | 3,057.3000 | 1,375.9000 | ||||||
| Fixed Assets | 9,643.8860 | 12,804.5000 | 14,144.6000 | 15,779.3000 | 17,648 | ||||||
| Inventories | 804.0220 | 893.4000 | 1,001.6000 | 902.7000 | 929.9000 | ||||||
| Accounts Receivable | 1,292.4450 | 1,227 | 1,441.6000 | 1,787 | 1,958.5000 | ||||||
| Cash and Cash Equivalents | 1,204.9240 | 1,308 | 2,326.5000 | 1,573.8000 | 1,224.6000 | ||||||
| Current Assets | 4,672.6730 | 6,700.3000 | 8,732.2000 | 7,873.3000 | 7,640.9000 | ||||||
| Total Assets | 14,316.5590 | 19,504.8000 | 22,876.8000 | 23,652.6000 | 25,288.9000 | ||||||
Liabilities
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 229.1780 | 267.4000 | 279.8000 | 395.5000 | 370.5000 | ||||||
| Long-term debt | 582.0610 | 6,521.5000 | 6,512.7000 | 5,935 | 5,936.5000 | ||||||
| Liabilities to Banks | 582.1000 | 6,521.5000 | 6,512.7000 | 5,935 | 5,936.5000 | ||||||
| Provisions | 218.8000 | 333.6000 | 325 | 190.8000 | 1,699.7000 | ||||||
| Liabilities | 3,502.5190 | 10,129.9000 | 10,748.2000 | 11,054.5000 | 12,257.3000 | ||||||
| Share Capital | .1290 | .1000 | .1000 | .1000 | .1000 | ||||||
| Total Equity | 10,814.0400 | 9,374.9000 | 12,128.6000 | 12,598.1000 | 13,031.6000 | ||||||
| Minority Interests | 5.0300 | 2.1000 | -11.5000 | -14.7000 | -8 | ||||||
| Total liabilities equity | 14,316.5590 | 19,504.8000 | 22,876.8000 | 23,652.6000 | 25,288.9000 | ||||||
Income Statement
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 9,703.3240 | 10,763.8000 | 11,448.8000 | 12,273.9000 | 13,452.9000 | ||||||
| Depreciation (total) | 688.1500 | 600.4000 | 682.7000 | 1,081 | 1,016.6000 | ||||||
| Operating Result | 3,972.4140 | 4,891 | 5,150.4000 | 5,344.2000 | 5,888.6000 | ||||||
| Interest Income | -17.3000 | -73.4000 | -196.6000 | -172.3000 | -88.1000 | ||||||
| Income Before Taxes | 3,946.6330 | 4,767.3000 | 4,933 | 5,128.8000 | 5,899.6000 | ||||||
| Income Taxes | 989.9420 | 1,161.6000 | 1,237.3000 | 2,458.7000 | 1,425.6000 | ||||||
| Minority Interests Profit | 6.7810 | 46.2000 | -7.1000 | 131 | 43.3000 | ||||||
| Net Income | 2,934.7840 | 3,547 | 3,702.8000 | 2,539.1000 | 4,430.7000 | ||||||
Per Share
Cash Flow
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 2,942.1150 | 3,716.1000 | 4,522.4000 | 4,551 | 6,187.7000 | ||||||
| Cash Flow from Investing Activities | -1,542.9760 | -4,553.6000 | -2,484.8000 | -2,963.1000 | -2,046.3000 | ||||||
| Cash Flow from Financing | -755.8730 | 986.4000 | -987.8000 | -2,380 | -4,472 | ||||||
| Decrease / Increase in Cash | 643.2660 | 148.9000 | 1,049.8000 | -792.1000 | -330.6000 | ||||||
| Employees | 7,550 | 7,350 | 7,400 | 7,300 | 7,800 | ||||||
